Thrivent Financial For Lutherans Abbott Laboratories Transaction History

Thrivent Financial For Lutherans

$49.6 Billion
Q2 2024

A detailed history of Thrivent Financial For Lutherans transactions in Abbott Laboratories stock. As of the latest transaction made, Thrivent Financial For Lutherans holds 479,241 shares of ABT stock, worth $54.3 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares

479,241

Previous 458,761 4.46%

Holding current value

$54.3 Million

Previous $52.1 Million 4.5%

% of portfolio

0.1%

Previous 0.1%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$100.73 - $112.44 $2.06 Million - $2.3 Million	20,480 Added 4.46%	479,241 $49.8 Million
Q1 2024 May 14, 2024	SELL	$109.52 - $120.96 $12.2 Million - $13.5 Million	-111,385 Reduced 19.54%	458,761 $52.1 Million
Q4 2023 Feb 14, 2024	BUY	$90.19 - $110.4 $419,383 - $513,360	4,650 Added 0.82%	570,146 $62.8 Million
Q3 2023 Nov 14, 2023	BUY	$95.53 - $114.62 $2.74 Million - $3.29 Million	28,691 Added 5.34%	565,496 $54.8 Million
Q2 2023 Aug 14, 2023	SELL	$100.78 - $112.29 $1.05 Million - $1.17 Million	-10,408 Reduced 1.9%	536,805 $58.5 Million
Q1 2023 May 17, 2023	SELL	$96.86 - $114.01 $2.19 Million - $2.58 Million	-22,601 Reduced 3.97%	547,213 $55.4 Million
Q4 2022 Feb 08, 2023	SELL	$95.06 - $111.52 $10.8 Million - $12.6 Million	-113,394 Reduced 16.6%	569,814 $62.6 Million
Q3 2022 Nov 14, 2022	BUY	$96.76 - $112.03 $2.44 Million - $2.83 Million	25,268 Added 3.84%	683,208 $66.1 Million
Q2 2022 Aug 16, 2022	BUY	$102.07 - $123.37 $14.8 Million - $17.9 Million	145,122 Added 28.3%	657,940 $71.5 Million
Q1 2022 May 13, 2022	BUY	$114.02 - $139.04 $31 Million - $37.8 Million	271,635 Added 112.63%	512,818 $61.1 Million
Q4 2021 Feb 16, 2022	SELL	$115.53 - $141.46 $3.88 Million - $4.76 Million	-33,625 Reduced 12.24%	241,183 $33.3 Million
Q3 2021 Nov 15, 2021	BUY	$116.66 - $129.06 $3.36 Million - $3.72 Million	28,804 Added 11.71%	274,808 $32.5 Million
Q2 2021 Sep 24, 2021	BUY	$105.79 - $124.53 $1.01 Million - $1.19 Million	9,561 Added 4.04%	246,004 $28.5 Million
Q2 2021 Aug 19, 2021	SELL	$105.79 - $124.53 $14.1 Million - $16.6 Million	-133,407 Reduced 36.07%	236,443 $27.4 Million
Q1 2021 May 17, 2021	SELL	$108.84 - $128.23 $8.8 Million - $10.4 Million	-80,818 Reduced 17.93%	369,850 $44.3 Million
Q4 2020 Feb 16, 2021	SELL	$105.0 - $114.42 $2.13 Million - $2.33 Million	-20,325 Reduced 4.32%	450,668 $49.3 Million
Q3 2020 Nov 10, 2020	SELL	$91.64 - $111.29 $7.02 Million - $8.52 Million	-76,592 Reduced 13.99%	470,993 $51.3 Million
Q2 2020 Aug 12, 2020	BUY	$76.57 - $98.0 $22,358 - $28,616	292 Added 0.05%	547,585 $49.6 Million
Q1 2020 May 15, 2020	BUY	$62.82 - $91.86 $3.36 Million - $4.91 Million	53,498 Added 10.83%	547,293 $43.2 Million
Q4 2019 Feb 13, 2020	SELL	$78.51 - $87.4 $78.7 Million - $87.6 Million	-1,002,713 Reduced 67.0%	493,795 $42.9 Million
Q3 2019 Nov 14, 2019	SELL	$81.84 - $88.74 $10.4 Million - $11.3 Million	-127,508 Reduced 7.85%	1,496,508 $125 Million
Q2 2019 Aug 13, 2019	BUY	$72.88 - $85.0 $27.7 Million - $32.3 Million	380,062 Added 30.55%	1,624,016 $137 Million
Q1 2019 May 14, 2019	BUY	$66.22 - $80.06 $72.5 Million - $87.7 Million	1,094,841 Added 734.24%	1,243,954 $99.4 Million
Q4 2018 Feb 15, 2019	BUY	$65.56 - $74.27 $158,261 - $179,287	2,414 Added 1.65%	149,113 $10.8 Million
Q3 2018 Nov 15, 2018	BUY	$60.81 - $73.36 $126,910 - $153,102	2,087 Added 1.44%	146,699 $10.8 Million
Q2 2018 Aug 14, 2018	SELL	$57.57 - $63.54 $5.07 Million - $5.6 Million	-88,068 Reduced 37.85%	144,612 $8.82 Million
Q1 2018 May 08, 2018	BUY	$56.27 - $63.62 $8.3 Million - $9.38 Million	147,476 Added 173.09%	232,680 $13.9 Million
Q4 2017 Feb 14, 2018	BUY	$53.68 - $57.47 $260,670 - $279,074	4,856 Added 6.04%	85,204 $4.86 Million
Q3 2017 Nov 14, 2017	BUY	$48.06 - $53.64 $3.86 Million - $4.31 Million	80,348	80,348 $4.29 Million

Others Institutions Holding ABT

# of Institutions

3,162

Shares Held

1.33B

Call Options Held

8.63M

Put Options Held

7.19M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $199B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Thrivent Financial For Lutherans, based on Form 13F filings with the SEC.

News

Stay updated on Thrivent Financial For Lutherans with notifications on news.

Account

Thrivent Financial For Lutherans Abbott Laboratories Transaction History